salbutamol

(redirected from Albuterol sulfate)
Also found in: Medical.
Related to Albuterol sulfate: budesonide, salbutamol, Ventolin

sal·bu·ta·mol

 (săl-byo͞o′tə-môl′, -mōl′, -mŏl′)
n.

[sal(icyl), the radical of salicylic acid (from French salicyle; see salicylic acid) + but(yl) + am(ine) + -ol.]

salbutamol

(sælˈbjuːtəˌmɒl)
n
(Pharmacology) a drug used in treating asthma
Translations

salbutamol

n salbutamol m
Mentioned in ?
References in periodicals archive ?
They pointed, for example, to the price hike for albuterol sulfate used to treat asthma and other lung conditions.
Prescribing data for 3,366 other adults not receiving psychotropics but receiving the asthma medication albuterol sulfate or obesity medications orlistat, phentermine, and sibutramine also were pulled to confirm study validity (assay sensitivity).
An inhalation spray containing ipratropium bromide and albuterol sulfate has been approved for patients with chronic obstructive pulmonary disease, according to a statement issued by the Food and Drug Administration.
Previous data have shown BIS to be stable chemically and compatible physically when administered simultaneously with respiratory medications, including albuterol sulfate inhalation solution (Proventil[R]; Schering Corporation, Kenilworth, NJ), ipratropium bromide inhalation solution (Atrovent[R]; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT), and levalbuterol inhalation solution.
Canonsburg PA) won approval to sell a generic version of extended-release albuterol sulfate, the active ingredient of Dava Pharmaceuticals' VoSpire ER.
Nephron Pharmaceuticals introduces the first and only FDA approved generic version of Albuterol Sulfate Inhalation Solution, 0.
GAO estimated that the 2003 Medicare payment rate per patient, per month was between $119 to $129 higher than suppliers' acquisition costs for a typical monthly supply of albuterol sulfate and between $162 to $187 higher for a typical monthly supply of ipratropium bromide.
1986 Acute respiratory Not stated (Finland) (24) infection with cough (mean duration=8 days) Hueston, 1991 Productive cough No clinical or radio- (USA) (25) of <30 days' duration graphic evidence of pneumonia Study Participants Withdrawals Interventions CHILDREN Bernard, 1999 13 Albuterol syrup vs placebo (USA) (19) syrup for 7 days Korppi, 1991 3 Albuterol + dextromethorphan (Finland) (23) syrup vs dextrome- thorphan syrup alone for 3 days ADULTS Littenberg, 1996 38 0ral albuterol sulfate (USA) (20) vs placebo for 7 days Hueston, 1994 0 Albuterol inhaler vs placebo (USA) (21) inhaler for 7 days; each group also received erythromycin or placebo capsules Melbye, 1991 11 Fenoterol inhaler vs (Norway) (22) placebo inhaler for 7 days Tukiainen.
Atrovent HFA is the latest inhalation aerosol approved by the Food and Drug Administration after reformulation without CFCs; others include fluticasone HFA (Flovent HFA Inhalation Aerosol, GlaxoSmithKline) and two formulations of albuterol sulfate HFA (Proventil HFA, 3M Pharmaceuticals; Ventolin HFA, GlaxoSmithKline).
Dhuper S, Foss S "Particle Size Output and Distribution Testing for Albuterol sulfate using 5 Spacer/Holding Chambers with Metered Dose Inhalers".
5% Albuterol Sulfate Inhalation Solution is the first FDA approved packaging of this medication in 0.